People · Operator

Paul M. Herron

Named in public records as an officer, director or promoter · active 2012–2014 · Biotechnology

1
Companies
4
Filings
$8.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Sun BioPharma, Inc.BiotechnologySeed$8.0M$52.2M2012
Operator network

Paul M. Herron at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

DAVID B. KAYSEN · 4 companies · 1 sharedDAVID B. KAYSENThomas X. Neenan · 3 companies · 1 sharedThomas X. NeenanD. Robert Schemel · 2 companies · 1 sharedD. Robert SchemelJeffrey R. Harder · 2 companies · 1 sharedJeffrey R. HarderMichael T. Cullen · 2 companies · 1 sharedMichael T. CullenPAUL W. SCHAFFER · 2 companies · 1 sharedPAUL W. SCHAFFERChristopher R. Johnson · 1 companies · 1 sharedChristopher R. Jo…Clifford F. McCurdy, III · 1 companies · 1 sharedClifford F. McCur…Daniel E. Ryweck · 1 companies · 1 sharedDaniel E. RyweckDonald R. Schemel · 1 companies · 1 sharedDonald R. SchemelDouglas M. Polinsky · 1 companies · 1 sharedDouglas M. Polins…Randall L. Johnson · 1 companies · 1 sharedRandall L. JohnsonRyan R. Gilbertson · 1 companies · 1 sharedRyan R. GilbertsonSuzanne X. Gagnon · 1 companies · 1 sharedSuzanne X. GagnonSun BioPharma, Inc. · $8.0M raisedSun BioPharma, Inc.Paul M. HerronPH
Paul M. Herron Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Paul M. Herron on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
DAVID B. KAYSEN14
Thomas X. Neenan13
D. Robert Schemel12
PAUL W. SCHAFFER12
Jeffrey R. Harder12
Michael T. Cullen12
Douglas M. Polinsky11
Ryan R. Gilbertson11
Christopher R. Johnson11
Clifford F. McCurdy, III11
Suzanne X. Gagnon11
Donald R. Schemel11
Daniel E. Ryweck11
Randall L. Johnson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.